ATXN2 and Hypercholesterolemia: Studies demonstrated that an ATXN2 KO mouse model is associated with a metabolic syndrome, involving hypercholesterolemia and diabetes mellitus, possibly related with a post-transcriptional effect of ATXN2 on the insulin receptor expression in liver and in cerebellum (Lastres-Becker et al. 2008).